Erik Sims
Corporate Officer/Principal chez OCUPHIRE PHARMA, INC.
Profil
Erik Sims is currently working as the Senior Director-Finance at Ocuphire Pharma, Inc. He previously worked as the Assistant Controller at Gemphire Therapeutics, Inc. Mr. Sims holds an MBA from Walsh College and an undergraduate degree from the University of Michigan-Flint.
Postes actifs de Erik Sims
| Sociétés | Poste | Début |
|---|---|---|
| OCUPHIRE PHARMA, INC. | Corporate Officer/Principal | 01/06/2023 |
Anciens postes connus de Erik Sims
| Sociétés | Poste | Fin |
|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Erik Sims
| Walsh College | Masters Business Admin |
| University of Michigan-Flint | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OCUPHIRE PHARMA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
